Pfizer Inc's experimental antiviral pill to treat COVID-19 cut by 89% the chances of hospitalization or death for adults at risk of severe disease, the company said on Friday.
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen.Pfizer Inc's experimental antiviral pill to treat COVID-19 cut by 89% the chances of hospitalization or death for adults at risk of severe disease, the company said on Friday, as its CEO vowed to make this promising new weapon in the fight against the pandemic available globally as quickly as possible.
Shares in Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, were up 9% to $47.82, while Merck's were down 9.3% to $82.09. Shares of vaccine makers took a hit, with Moderna Inc, Pfizer's German partner BioNTech SE and Novavax all down 13-21%. Pfizer is in active discussions with 90 countries over supply contracts for its pill, Chief Executive Officer Albert Bourla said in an interview.Bourla said that for high-income countries Pfizer expects to price its treatment close to where Merck has priced its pill. Merck's U.S. contract price is around $700 for a five-day course of therapy. For low-income countries, Bourla said Pfizer is considering several options, with the goal of"no barrier for them as well to have access.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%Pfizer Inc's experimental antiviral pill to treat COVID-19 cut by 89% the chances of hospitalization or death for adults at risk of severe disease, the company said on Friday.
Read more »
COVID-19 LIVE UPDATES | SA records 24 new Covid-19 deaths as total cases near 3mCoronavirus live updates
Read more »
Pfizer seeks US approval for its Covid-19 pillPfizer is seeking US regulatory approval for its Covid-19 pill which, it says, reduces hospitalisations and deaths in high-risk patients by 89%.
Read more »
Covid-19 SRD grant: 'No fixed payment dates' – SassaSassa said the Covid-19 SRD grant beneficiaries that there is no fixed payment date for the grant; beneficiaries must apply every month.
Read more »
COVID-19 | 23m vaccine doses administered in SAOver 23 million doses of COVID-19 vaccines have been administered in South Africa.
Read more »
Covid-19: SA records 339 new cases, 44 deaths in 24 hoursSA recorded 339 new Covid-19 cases and 44 deaths in the past 24 hours, the National Institute for Communicable Diseases said on Friday.
Read more »